315 related articles for article (PubMed ID: 28439266)
1. A Novel Regulator of Activation-Induced Cytidine Deaminase/APOBECs in Immunity and Cancer: Schrödinger's CATalytic Pocket.
King JJ; Larijani M
Front Immunol; 2017; 8():351. PubMed ID: 28439266
[TBL] [Abstract][Full Text] [Related]
2. Structure-Based Design of First-Generation Small Molecule Inhibitors Targeting the Catalytic Pockets of AID, APOBEC3A, and APOBEC3B.
King JJ; Borzooee F; Im J; Asgharpour M; Ghorbani A; Diamond CP; Fifield H; Berghuis L; Larijani M
ACS Pharmacol Transl Sci; 2021 Aug; 4(4):1390-1407. PubMed ID: 34423273
[TBL] [Abstract][Full Text] [Related]
3. DNA deamination in immunity: AID in the context of its APOBEC relatives.
Conticello SG; Langlois MA; Yang Z; Neuberger MS
Adv Immunol; 2007; 94():37-73. PubMed ID: 17560271
[TBL] [Abstract][Full Text] [Related]
4. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
He X; Li J; Wu J; Zhang M; Gao P
Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
[TBL] [Abstract][Full Text] [Related]
5. AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19.
Meshcheryakova A; Pietschmann P; Zimmermann P; Rogozin IB; Mechtcheriakova D
Front Immunol; 2021; 12():690416. PubMed ID: 34276680
[TBL] [Abstract][Full Text] [Related]
6. The AID/APOBEC family of nucleic acid mutators.
Conticello SG
Genome Biol; 2008; 9(6):229. PubMed ID: 18598372
[TBL] [Abstract][Full Text] [Related]
7. APOBEC3s: DNA-editing human cytidine deaminases.
Silvas TV; Schiffer CA
Protein Sci; 2019 Sep; 28(9):1552-1566. PubMed ID: 31241202
[TBL] [Abstract][Full Text] [Related]
8. Secreted novel AID/APOBEC-like deaminase 1 (SNAD1) - a new important player in fish immunology.
Majewska AM; Dietrich MA; Budzko L; Adamek M; Figlerowicz M; Ciereszko A
Front Immunol; 2024; 15():1340273. PubMed ID: 38601149
[TBL] [Abstract][Full Text] [Related]
9. Structural plasticity of substrate selection by activation-induced cytidine deaminase as a regulator of its genome-wide mutagenic activity.
King JJ; Larijani M
FEBS Lett; 2021 Jan; 595(1):3-13. PubMed ID: 33089497
[TBL] [Abstract][Full Text] [Related]
10. The optimal pH of AID is skewed from that of its catalytic pocket by DNA-binding residues and surface charge.
Ghorbani A; King JJ; Larijani M
Biochem J; 2022 Jan; 479(1):39-55. PubMed ID: 34870314
[TBL] [Abstract][Full Text] [Related]
11. Pichia pastoris as a host for production and isolation of mutagenic AID/APOBEC enzymes involved in cancer and immunity.
Borzooee F; Larijani M
N Biotechnol; 2019 Jul; 51():67-79. PubMed ID: 30822538
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like Gene Expression, RNA Editing, and MicroRNAs Regulation.
Cao W; Wu W
Methods Mol Biol; 2018; 1699():75-81. PubMed ID: 29086369
[TBL] [Abstract][Full Text] [Related]
13. AID/APOBEC-like cytidine deaminases are ancient innate immune mediators in invertebrates.
Liu MC; Liao WY; Buckley KM; Yang SY; Rast JP; Fugmann SD
Nat Commun; 2018 May; 9(1):1948. PubMed ID: 29769532
[TBL] [Abstract][Full Text] [Related]
14. Catalytic pocket inaccessibility of activation-induced cytidine deaminase is a safeguard against excessive mutagenic activity.
King JJ; Manuel CA; Barrett CV; Raber S; Lucas H; Sutter P; Larijani M
Structure; 2015 Apr; 23(4):615-27. PubMed ID: 25728927
[TBL] [Abstract][Full Text] [Related]
15. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
Conticello SG; Thomas CJ; Petersen-Mahrt SK; Neuberger MS
Mol Biol Evol; 2005 Feb; 22(2):367-77. PubMed ID: 15496550
[TBL] [Abstract][Full Text] [Related]
16. Mice deficient in APOBEC2 and APOBEC3.
Mikl MC; Watt IN; Lu M; Reik W; Davies SL; Neuberger MS; Rada C
Mol Cell Biol; 2005 Aug; 25(16):7270-7. PubMed ID: 16055735
[TBL] [Abstract][Full Text] [Related]
17. The preferred nucleotide contexts of the AID/APOBEC cytidine deaminases have differential effects when mutating retrotransposon and virus sequences compared to host genes.
Chen J; MacCarthy T
PLoS Comput Biol; 2017 Mar; 13(3):e1005471. PubMed ID: 28362825
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like family genes activation and regulation during tumorigenesis.
Gao J; Choudhry H; Cao W
Cancer Sci; 2018 Aug; 109(8):2375-2382. PubMed ID: 29856501
[TBL] [Abstract][Full Text] [Related]
19. APOBECs orchestrate genomic and epigenomic editing across health and disease.
Cervantes-Gracia K; Gramalla-Schmitz A; Weischedel J; Chahwan R
Trends Genet; 2021 Nov; 37(11):1028-1043. PubMed ID: 34353635
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases.
Koito A; Ikeda T
Front Microbiol; 2013; 4():28. PubMed ID: 23431045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
